EU - Draft Commission Implementing Decision on the group of products whose principal intended action, depending on proanthocyanidins (PAC) present in cranberry (Vaccinium Macrocarpon), is to prevent or treat cystitis

This draft Commission Decision aims at qualifying the group of products whose principal intended action, depending on proanthocyanidins (PAC) present in cranberry (Vaccinium Macrocarpon), is to prevent or treat cystitis as not medical devices.

Proposed date of adoption: February/March 2017

Proposed date of entry into force: 20 days from publication in the Official Journal of the EU

Final date for comments: 60 days from notification

If the Proposal/Notification/Regulation will affect your International Business please send us your representation with facts and figures before 20 February 2016, so that these can be taken up suitably.